Mevalonate pathway inhibitor as highly-efficient vaccine adjuvant
US-2022387584-A1 · Dec 8, 2022 · US
US9627627B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9627627-B2 |
| Application number | US-201314014732-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 30, 2013 |
| Priority date | Sep 14, 2012 |
| Publication date | Apr 18, 2017 |
| Grant date | Apr 18, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A phosphine oxide-based compound represented by Formula 1, and an organic light-emitting device including the phosphine oxide-based compound. wherein Ar 1 through Ar 3 , and a, b, and c are defined as in the specification.
Opening claim text (preview).
What is claimed is: 1. A phosphine oxide-based compound represented by Formula 1 below: wherein Ar 1 to Ar 3 are each independently deuterium, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, hydrazine, hydrazone, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, or an N-containing electron withdrawing group; a, b and c are each independently an integer from 0 to 5; the sum of a, b, and c must be greater than or equal to 1; and at least one of a number of Ar 1 s, b number of Ar 2 s, and c number of Ar 3 s is an N-containing electron withdrawing group, wherein the N-containing electron withdrawing group is selected from among: a substituted or unsubstituted pyrrolyl group, a substituted or unsubstituted pyrazolyl group, an unsubstituted imidazolyl group, a substituted or unsubstituted imidazolinyl group, a substituted or unsubstituted imidazopyridinyl group, a substituted or unsubstituted imidazopyrimidinyl group, a substituted or unsubstituted pyrazinyl group, an unsubstituted pyrimidinyl group, a substituted benzoimidazolyl group, a substituted or unsubstituted indolyl group, a substituted or unsubstituted purinyl group, a substituted or unsubstituted quinolinyl group, a substituted or unsubstituted isoquinolyl group, a substituted or unsubstituted phthalazinyl group, a substituted or unsubstituted indolizinyl group, a substituted or unsubstituted naphthyridinyl group, a substituted or unsubstituted quinazolinyl group, a substituted or unsubstituted cinnolinyl group, a substituted or unsubstituted indazolyl group, a substituted or unsubstituted isothiazolyl group, a substituted or unsubstituted isoxazolyl group, a substituted or unsubstituted triazinyl group, a substituted or unsubstituted oxadiazolyl group, a substituted or unsubstituted pyridazinyl group, a substituted or unsubstituted triazolyl group, a substituted or unsubstituted tetrazolyl group, a substituted or unsubstituted benzothiazolyl group, and a substituted or unsubstituted benzoxazolyl group. 2. The phosphine oxide-based compound of claim 1 , wherein the N-containing electron withdrawing group is selected from among: an unsubstituted pyrimidinyl group, a substituted or unsubstituted pyrazinyl group, a substituted or unsubstituted triazinyl group, a substituted or unsubstituted quinolinyl group, a substituted or unsubstituted isoquinolinyl group, a substituted benzoimidazolyl group, a substituted or unsubstituted imidazopyridinyl group, a substituted or unsubstituted imidazopyrimidinyl group, a substituted or unsubstituted benzothiazolyl group, and a substituted or unsubstituted benzoxazolyl group. 3. The phosphine oxide-based compound of claim 1 , wherein the N-containing electron withdrawing group is represented by one of Formulae 2C to 2L: wherein Z 1 and Z 2 are each independently selected from deuterium, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, hydrazine, hydrazone, a carboxyl group and a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 10 cycloalkyl group, a C 3 -C 10 cycloalkenyl group and a C 6 -C 60 aryl group; a C 6 -C 60 aryl group substituted with at least one of —F, —CN, and a C 1 -C 10 alkyl group; and a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group and a C 2 -C 60 heteroaryl group; c 1 is an integer from 0 to 4; c 2 is an integer of 0 to 3; c 3 is an integer from 0 to 2; c 4 is an integer of 0 to 6; c 5 is an integer from 0 to 5; and T 1 is O or S. 4. The phosphine oxide-based compound of claim 3 , wherein the Z 1 and Z 2 are each independently deuterium, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, hydrazine, hydrazone, a carboxylic group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a phenyl group, a naphthyl group, an anthryl group, or a phenanthrenyl group. 5. The phosphine oxide-based compound of claim 2 , wherein the N-containing electron withdrawing group is represented by Formula 2I below: wherein Z 1 is a phenyl group, a naphthyl group, an anthryl group, or a phenanthrenyl group, and Z 2 is independently selected from deuterium, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, hydrazine, hydrazone, a carboxyl group and a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 10 cycloalkyl group, a C 3 -C 10 cycloalkenyl group and a C 6 -C 60 aryl group; a C 6 -C 60 aryl group substituted with at least one of —F, —CN, and a C 1 -C 10 alkyl group; and a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group and a C 2 -C 60 heteroaryl group; and c 1 is an integer from 0 to 4. 6. The phosphine oxide-based compound of claim 1 , wherein at least two of the a number of Ar 1 s, the b number of Ar 2 s, and the c number of Ar 3 s are N-containing electron withdrawing groups. 7. The phosphine oxide-based compound of claim 1 , wherein a, b, and c are all 1, and at least two of Ar 1 , Ar 2 , and Ar 3 are N-containing electron withdrawing groups. 8. The phosphine oxide-based compound of claim 1 , wherein the phosphine oxide-based compound is a compound represented by Formula 1A below: wherein Ar 1 to Ar 3 are each independently deuterium, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, hydrazine, hydrazone, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a sub
Platinum compounds · CPC title
without a metal-carbon linkage · CPC title
Iridium compounds · CPC title
without a metal-carbon linkage · CPC title
containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.